Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • china cas 95810-54-1 butonitazene

Nov . 08, 2024 17:57 Back to list

china cas 95810-54-1 butonitazene



Understanding Butonitazene A Focus on China CAS 95810-54-1


Butonitazene, with the Chemical Abstracts Service (CAS) registry number 95810-54-1, is a synthetic opioid that has garnered increasing attention in both scientific research and public health discussions. Classified under the broader category of novel psychoactive substances (NPS), butonitazene has piqued curiosity due to its unique properties and potential implications for both therapeutic use and substance abuse.


Chemical Structure and Properties


Butonitazene belongs to the benzimidazole class of compounds. Its intricate chemical structure is designed to interact with the body's opioid receptors, particularly the mu-opioid receptor, which is predominantly responsible for the effects of pain relief and euphoria. This interaction is similar to that of other opioids, but crucially, butonitazene exhibits a higher potency. It implies that significantly lower doses are required to achieve similar effects compared to other common opioids like morphine or fentanyl.


Historical Context and Development

First synthesized in the mid-20th century, butonitazene did not initially enter the medical mainstream. Instead, it remained largely within academic and research environments, where scientists sought to explore its pharmacological properties. As the landscape of drug design evolved, butonitazene and similar compounds found renewed interest among researchers, especially as the opioid crisis garnered attention globally.


Potential Therapeutic Applications


Research into butonitazene has indicated that this synthetic opioid could possess potential therapeutic applications. Its high potency suggests it could be beneficial for managing severe pain in clinical settings, particularly where traditional opioids may be ineffective or raise concerns over abuse potential. However, extensive clinical trials and regulatory approvals would be necessary before it could be adopted into standard medical practice.


china cas 95810-54-1 butonitazene

china cas 95810-54-1 butonitazene

Risks and Concerns


Despite its potential benefits, butonitazene raises significant concerns regarding safety and abuse. The enhanced potency can lead to a higher risk of overdose, a critical issue that has shadowed the opioid class for decades. Moreover, as with many novel psychoactive substances, the lack of comprehensive research on its long-term effects poses challenges for public health authorities and healthcare providers.


Widespread availability in online markets, often through unregulated sources, exacerbates the issue of misuse. There is a pressing need for monitoring and regulation of such substances to prevent them from becoming commonplace in illicit drug markets. Countries like China, where many synthetic drugs are manufactured, play a crucial role in this dynamic.


Regulatory Landscape


As awareness of butonitazene grows, regulatory agencies worldwide are faced with the challenge of managing its distribution and use. Several countries have started to list it under controlled substances to prevent abuse while promoting research into its medical applications. Effective legal frameworks are essential to balance the potential therapeutic benefits against the backdrop of rising addiction and even fatalities associated with synthetic opioids.


Conclusion


Butonitazene (CAS 95810-54-1) stands at the intersection of medical promise and public health concern. As research continues to unravel its properties and effects, there is hope that it may one day contribute positively to pain management therapies. However, its association with abuse and the urgent need for regulation cannot be overlooked. The future of butonitazene will depend on a concerted effort by researchers, healthcare professionals, and policymakers to ensure that any benefits can be harnessed responsibly and safely within society.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish